Last reviewed · How we verify
Severe Pain with Opioid Tolerance
Approved treatments
- Dilaudid-Hp · Fresenius Kabi
Hydromorphone binds primarily to mu-opioid receptors, producing analgesia without a ceiling effect. - Naltrexon · Institute of Liver and Biliary Sciences, India
- Dilaudid-Hp · Fresenius Kabi
Full mu-opioid receptor agonist providing analgesia through CNS opioid receptor activation. - Opana Er · Endo
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Severe Pain with Opioid Tolerance patent landscape — cliff calendar, originator estates, attackable patents
- Severe Pain with Opioid Tolerance treatment landscape brief
- Severe Pain with Opioid Tolerance treatment updates RSS
Frequently asked questions about Severe Pain with Opioid Tolerance
What drugs treat Severe Pain with Opioid Tolerance?
Tracked treatments include Dilaudid-Hp, Naltrexon, Opana Er.
What is the treatment for Severe Pain with Opioid Tolerance?
Standard treatment for Severe Pain with Opioid Tolerance includes Dilaudid-Hp, Naltrexon, Opana Er. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Severe Pain with Opioid Tolerance patent cliff · Severe Pain with Opioid Tolerance CI report
- Treatment: Dilaudid-Hp · Fresenius Kabi
- Treatment: Naltrexon · Institute of Liver and Biliary Sciences, India
- Treatment: Dilaudid-Hp · Fresenius Kabi
- Treatment: Opana Er · Endo
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing